创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

生物碱防治非酒精性脂肪肝病药理作用与机制的研究进展

Research Progress in Pharmacological Effects and Action Mechanisms of Alkaloids for the Prevention and Treatment of Non-alcoholic Fatty Liver Diseases

  • 摘要: 随着国民生活水平的提高,非酒精性脂肪肝病的发病率和死亡率不断增加。非酒精性脂肪肝病的发病机制复杂,针对该疾病的药物研发进程缓慢。由于生物碱具有抗氧化和抗炎等多种生物活性,近年来其防治非酒精性脂肪肝病的药理作用与机制受到广泛关注。围绕近年来的研究热点,对有机胺类、哌啶类、异喹啉类、黄嘌呤类生物碱防治非酒精性脂肪肝病的药理作用与机制研究进展进行综述,旨在为非酒精性脂肪肝病治疗药物的研发或先导化合物的发现提供参考和依据。

     

    Abstract: The morbidity and mortality of non-alcoholic fatty liver diseases (NAFLD) are continuously increasing with the improvement in living standards. The pathogenesis of NAFLD is very complex, leading to retarded progress in the development of NAFLD drugs. Recently, due to the prominent bioactivities of alkaloids such as anti-oxidation and anti-inflammation, researches on their pharmacological effects and action mechanisms in the prevention and treatment of NAFLD have gained widespread attention. With a focus on recent hot topics, this article reviewed the research progress in pharmacological effects and action mechanisms of alkaloids for the prevention and treatment of NAFLD, including organic amine alkaloids, piperidine alkaloids, isoquinoline alkaloids and xanthine alkaloids, so as to provide insights into the development of NAFLD drugs and discovery of lead compounds.

     

/

返回文章
返回